Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting

Go back to Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
(NASDAQ: CRVS) Delayed: 12.56 +0.65 (5.46%)
Previous Close $11.91    52 Week High $17.77 
Open $12.46    52 Week Low $9.63 
Day High $12.83    P/E N/A 
Day Low $12.25    EPS $0.00 
Volume 1,388,522